Skip to main content
    T

    Transcat Inc (TRNS)

    Official site

    INDUSTRIALS • SPECIALTY BUSINESS SERVICES • NASDAQ

    $99.65
    -2.05 (-2.02%)

    Market Cap: $956.47M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Transcat Inc (TRNS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Transcat (TRNS) has a market cap of $956.47M and an enterprise value of $1.07B. Revenue grew 20.04% over the last 12 months from the 12 months before. Its trailing P/E of 50.6x is above its 10-year median of 35.7x.

    Total Valuation

    Enterprise value is 11.62% above the market cap, as debt exceeds cash.

    Market Cap$956.47M
    Enterprise Value$1.07B
    Latest price (Nov 17, 2026)$99.65

    Key Dates

    The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 1, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Fiscal Year EndMarch

    Share Statistics

    The share count rose 0.40% in the quarter ended Sep 30, 2026 and grew 1.25% a year over 2 years.

    Shares Outstanding9.39M
    Shares Change (YoY)+0.74%
    Shares Change (QoQ)+0.40%
    Share Count Growth (2Y CAGR)+1.25%

    Valuation Ratios

    Sales and book value multiples are 2.6x and 3.0x. Its year-end P/E ranged from 16.9x to 60.4x from 2016 to 2025.

    P/E Ratio50.6x
    Forward P/E46.0x
    P/S Ratio2.6x
    Forward P/S2.5x
    P/B Ratio3.0x
    P/FCF Ratio40.7x
    P/OCF Ratio25.6x
    PEG Ratio3.1

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 25.7x EBITDA and 45.6x free cash flow.

    EV / Earnings232.6x
    EV / Sales2.9x
    EV / EBITDA25.7x
    EV / EBIT83.8x
    EV / FCF45.6x

    Price Statistics

    The stock is up 83.55% over 52 weeks and trades 11.15% above its 50-day average.

    Beta (1Y)1.63
    52-Week Change+83.55%
    1-Month Change+23.51%
    3-Month Change+8.59%
    6-Month Change+43.09%
    5-Year Change+15.26%
    10-Year Change+722.00%
    Total Return (1Y)+83.55%
    Total Return (3Y CAGR)+2.56%
    Total Return (5Y CAGR)+0.33%
    Return vs SPY (1Y)+76.11%
    Max Drawdown (1Y)-18.55%
    Max Drawdown (3Y)-63.86%
    Sharpe Ratio (1Y)1.28
    Correlation with SPY (1Y)0.45
    50-Day Average$89.65
    200-Day Average$84.05
    52-Week Range$50.23 to $112.44
    RSI (14 Days)55.2
    Average Volume (20 Days)202.56K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.57x current liabilities, and total debt is 0.38x shareholder equity.

    Current Ratio2.57x
    Quick Ratio2.19x
    Debt / Equity0.38x
    Debt / EBITDA2.87x
    Debt / FCF5.09x
    Interest Coverage2.13x

    Returns and Efficiency

    Return on invested capital is 2.03% over the last 12 months, against a 5-year average of 6.07%.

    Return on Equity (ROE)1.48%
    Return on Assets (ROA)0.91%
    Return on Invested Capital (ROIC)2.03%
    Return on Capital Employed (ROCE)2.72%
    ROE (5Y Average)7.37%
    ROA (5Y Average)4.30%
    ROIC (5Y Average)6.07%
    Asset Turnover0.73x
    Inventory Turnover16.48x
    Receivables Turnover5.21x
    Cash Conversion Cycle61 days

    Taxes

    Income tax took 32.10% of pretax income over the last 12 months.

    Income Tax (TTM)$2.17M
    Effective Tax Rate32.10%

    Scores

    TRNS has an Altman Z-Score of 4.06, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score4.06
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $363.22M over the last 12 months.

    Revenue$363.22M
    Revenue Growth (YoY)+20.04%
    Gross Profit$119.08M
    Operating Income$13.17M
    Pretax Income$6.76M
    Net Income$4.59M
    EBITDA$40.77M
    EBIT$12.73M
    Reported EPS (TTM)$1.97

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 60.98% of the $507.06M in total assets.

    Cash and Equivalents$5.76M
    Total Debt$116.89M
    Net Debt$111.13M
    Net Debt Per Share$11.83
    Working Capital$60.99M
    Shareholder Equity$309.18M
    Book Value Per Share$32.93
    Tangible Book Value-$4.57M
    Total Assets$507.06M
    Total Liabilities$197.88M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $14.34M of capital spending, operating cash flow left $22.97M of free cash flow.

    Operating Cash Flow$37.31M
    Capital Expenditures$14.34M
    Free Cash Flow$22.97M
    FCF Per Share$2.45
    Depreciation and Amortization$28.04M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 3.63%, against a 5-year average of 6.40%.

    Gross Margin32.79%
    Operating Margin3.63%
    Pretax Margin1.86%
    Net Margin1.26%
    EBITDA Margin11.23%
    EBIT Margin3.51%
    FCF Margin6.32%
    Gross Margin (5Y Average)31.04%
    Operating Margin (5Y Average)6.40%
    Net Margin (5Y Average)4.46%

    Growth

    Revenue grew 12.91% a year over 3 years, and EPS fell 0.36% a year.

    Revenue Growth (3Y CAGR)+12.91%
    Revenue Growth (5Y CAGR)+13.87%
    EPS Growth (3Y CAGR)-0.36%
    EPS Growth (5Y CAGR)+11.37%
    FCF Growth (3Y CAGR)+37.40%
    FCF Growth (5Y CAGR)+2.81%
    Operating Income Growth (3Y CAGR)-6.54%
    Book Value Per Share Growth (2Y CAGR)+10.53%
    Tangible Book Per Share Growth (2Y CAGR)-79.16%

    Revenue and profit by year

    Dividends and Yields

    TRNS does not pay a dividend. Its free cash flow yield is 2.46%.

    Earnings Yield1.98%
    FCF Yield2.46%
    Buyback Yield-0.02%
    Shareholder Yield-0.02%

    Peer Position

    Against 8 similar companies, TRNS has the 2nd highest P/E.

    P/E Ratio50.6x vs 18.4x median
    P/S Ratio2.6x vs 0.8x median
    ROIC2.03% vs 3.93% median
    Revenue Growth (Trailing 4 Quarters, YoY)+20.04% vs +2.27% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 11.12% and EPS growth at 12.51% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+11.12%
    EPS Growth Forecast (2Y CAGR)+12.51%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About TRNS

    What is TRNS's market cap?

    Transcat has a market cap of $956.47M. Its enterprise value, which adds debt and subtracts cash, is $1.07B.

    What is TRNS's P/E ratio?

    Transcat has a trailing P/E ratio of 50.6x and a forward P/E of 46.0x.

    How many shares of TRNS are outstanding?

    Transcat has 9.39M shares outstanding. The count is up 0.74% from a year earlier.

    Does TRNS pay a dividend?

    No. Transcat does not pay a dividend.

    How much debt does TRNS have?

    Transcat has $116.89M of total debt and $5.76M of cash and equivalents, a net debt position of $111.13M.